Disaggregated Revenues

9 Months Ended

Sep. 30, 2020

Disaggregation of Revenue [Abstract]

Disaggregated Revenues

Disaggregated Revenues

The following table summarizes the disaggregation of revenues by product or source, (dollars in thousands):

	Three Months ended September 30,				Nine Months ended September 30,
	2020		2019		2020		2019
	(unaudited)				(unaudited)
Net product sales
Trokendi XR	$	82,906	$	77,332	$	241,131	$	219,989
Oxtellar XR	28,364		22,702		75,983		65,502
APOKYN	34,482		—		43,082		—
XADAGO	2,331		—		3,132		—
MYOBLOC	4,050		—		5,279		—
Total net product sales	$	152,133	$	100,034	$	368,607	$	285,491
Royalty revenues	3,002		2,106		8,233		6,818
Total revenues	$	155,135	$	102,140	$	376,840	$	292,309

Trokendi XR accounted for 65% and 77% of the Company’s total net product sales for the nine months ended September 30, 2020 and 2019, respectively.

The Company recognized noncash royalty revenue of $2.4 million and $6.3 million, for the three and nine months ended September 30, 2020, respectively. The Company recognized noncash royalty revenue of $1.6 million and $5.0 million, for the three and nine months ended September 30, 2019, respectively.